Rehaler_logo_RGB_alone_isolated_white.png
Investor news
Troels Johansen
  • Apr 6

Rehaler receives 2.18 million DKK from the Danish Innovation Fund for new migraine treatment

The Innovation Fund has awarded Rehaler an Innobooster grant for the large scale clinical trial aiming to validate the effect of the...
Troels Johansen
  • Dec 1, 2021

Rehaler closes financing round and strengthens Board of Directors

Rehaler closes financing round of 6.1m DKK and strengthens Board of Directors with four experienced profiles.